China Medical System CHSYF Stock
China Medical System Price Chart
China Medical System CHSYF Financial and Trading Overview
China Medical System stock price | 0.93 USD |
Previous Close | 1.46 USD |
Open | 1.46 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 1.46 - 1.46 USD |
52 Week Range | 1.28 - 1.6 USD |
Volume | 100 USD |
Avg. Volume | 34 USD |
Market Cap | 3.88B USD |
Beta (5Y Monthly) | 0.889272 |
PE Ratio (TTM) | 7.684211 |
EPS (TTM) | 0.14 USD |
Forward Dividend & Yield | 0.07 (4.79%) |
Ex-Dividend Date | May 3, 2023 |
1y Target Est | N/A |
CHSYF Valuation Measures
Enterprise Value | -336067072 USD |
Trailing P/E | 7.684211 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.42410192 |
Price/Book (mrq) | 0.24537817 |
Enterprise Value/Revenue | -0.037 |
Enterprise Value/EBITDA | -0.089 |
Trading Information
China Medical System Stock Price History
Beta (5Y Monthly) | 0.889272 |
52-Week Change | -8.17% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.6 USD |
52 Week Low | 1.28 USD |
50-Day Moving Average | 1.58 USD |
200-Day Moving Average | 1.47 USD |
CHSYF Share Statistics
Avg. Volume (3 month) | 34 USD |
Avg. Daily Volume (10-Days) | 10 USD |
Shares Outstanding | 2.45B |
Float | 1.24B |
Short Ratio | N/A |
% Held by Insiders | 49.55% |
% Held by Institutions | 19.40% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.534 |
Trailing Annual Dividend Yield | 36.57% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.4012 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 35.61% |
Operating Margin (ttm) | 38.82% |
Gross Margin | 76.89% |
EBITDA Margin | 41.10% |
Management Effectiveness
Return on Assets (ttm) | 13.23% |
Return on Equity (ttm) | 23.75% |
Income Statement
Revenue (ttm) | 9.15B USD |
Revenue Per Share (ttm) | 3.73 USD |
Quarterly Revenue Growth (yoy) | 4.59% |
Gross Profit (ttm) | 7.04B USD |
EBITDA | 3.76B USD |
Net Income Avi to Common (ttm) | 3.26B USD |
Diluted EPS (ttm) | 0.19 |
Quarterly Earnings Growth (yoy) | 5.09% |
Balance Sheet
Total Cash (mrq) | 5.88B USD |
Total Cash Per Share (mrq) | 2.4 USD |
Total Debt (mrq) | 1.81B USD |
Total Debt/Equity (mrq) | 12.3 USD |
Current Ratio (mrq) | 3.069 |
Book Value Per Share (mrq) | 5.95 |
Cash Flow Statement
Operating Cash Flow (ttm) | 3.55B USD |
Levered Free Cash Flow (ttm) | 2.09B USD |
Profile of China Medical System
Country | United States |
State | N/A |
City | North Point |
Address | Island Place Tower |
ZIP | N/A |
Phone | 852 2369 7678 |
Website | https://www.cms.net.cn |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 5647 |
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. It also offers DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company provides Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Q&A For China Medical System Stock
What is a current CHSYF stock price?
China Medical System CHSYF stock price today per share is 0.93 USD.
How to purchase China Medical System stock?
You can buy CHSYF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for China Medical System?
The stock symbol or ticker of China Medical System is CHSYF.
Which industry does the China Medical System company belong to?
The China Medical System industry is Drug Manufacturers-Specialty & Generic.
How many shares does China Medical System have in circulation?
The max supply of China Medical System shares is 2.44B.
What is China Medical System Price to Earnings Ratio (PE Ratio)?
China Medical System PE Ratio is 6.65214250 now.
What was China Medical System earnings per share over the trailing 12 months (TTM)?
China Medical System EPS is 0.14 USD over the trailing 12 months.
Which sector does the China Medical System company belong to?
The China Medical System sector is Healthcare.